A study to estimate improvement in quality of life, cost effectiveness of radiotherapy in patients of breast cancer with bone metastases.
Not Applicable
- Conditions
- Health Condition 1: null- Patients of breast cancer who have been newly diagnosed with bone metastases and who will be planned for palliative radiotherapy
- Registration Number
- CTRI/2018/03/012317
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Any breast cancer patient with newly diagnosed bone metastases.
2.Histological proof of malignancy of the breast.
Exclusion Criteria
1.Unwilling to give written informed consent.
2.Patients previously treated for bone metastases.
3.Unwilling for regular physical and or telephonic follow up
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To establish a cohort of breast cancer patients with bone metastases receiving standard <br/ ><br>evidence based management to study the morbidity related to bone metastases and clinically relevant skeletal related complications <br/ ><br>Timepoint: 5 years
- Secondary Outcome Measures
Name Time Method 1.To evaluate the severity and characteristics of pain at baseline and its response to treatment. <br/ ><br>2.Identify factors predicting 10% risk of pathological fracture at 1 year. <br/ ><br>3.Identify factors predicting 5% risk of clinical cord compression at 1 year <br/ ><br>4.Identify factors predicting an overall survival of less than 6 months in this patient population. <br/ ><br>Timepoint: 3 years